Dermatitis: A Nutritional and Natural-Health Reference
Definition and Overview
Dermatitis (eczema) represents a group of inflammatory cutaneous diseases. Also called eczema, it is generic inflammation of the skin. Dermatitis is a chronic inflammatory skin disorder characterized generally by redness, edema, oozing, crusting, scaling, and pruritus. The terms dermatitis and eczema are often used synonymously.
Dermatitis is a skin inflammatory disease commonly spreading in a limited area of the body and characterized by reddening, itching and skin dryness of the affected epidermis. It is a condition that can interfere with social function, sleep and employment. Its persistence and accompanying pruritus may be stressful and frustrating for patients.
Although different types of dermatitis have varying symptoms, there are certain signs common to all of them, including redness of the skin, swelling, itching, skin lesions, and sometimes oozing and scarring. The area of the skin on which the symptoms appear tends to differ with every type. Types of dermatitis are classified according to the cause of the condition.
Classification and Clinical Presentations
The broader group of dermatitis includes contact, atopic, seborrheic, and stasis dermatitis; hand, nummular, and asteatotic eczema, among others.
Atopic Dermatitis (AD)
Atopic dermatitis is a type of eczema and is an inflammatory, chronically relapsing, non-contagious and itchy skin disorder. It is a chronic inflammatory skin disease marked by pruritus and eczematous lesions that significantly impacts patient quality of life. A primary characteristic of atopic dermatitis is extreme itching, leading to repeated scratching which results in the typical lesions of eczema. Infantile eczema occurs predominantly on the cheeks, which may extend to other areas. Eczema occurring in children, adolescents, and adults is found predominantly on the flexural surfaces, especially on the antecubital and popliteal areas, and on the neck, eyelids, wrists, and behind the ears.
Atopic dermatitis is a chronic inflammatory skin disorder exhibited by individuals with a hereditary predisposition of a lowered cutaneous threshold to pruritus and is often accompanied by allergic rhinitis, hay fever, and asthma. Atopic dermatitis can have varied presentations, but the most common manifestations include erythematous papules that develop scaling, exudate, or xerosis.
Contact Dermatitis
Contact dermatitis is a localized rash or irritation of the skin caused by contact with a foreign substance. Only the superficial regions of the skin are affected; inflammation of the affected tissue is present in the epidermis and the outer dermis. Contact dermatitis is classified into three types: irritant contact, allergic contact, and photocontact dermatitis.
Irritant contact dermatitis accounts for 80% of all cases of contact dermatitis. Irritant contact dermatitis is provoked by handling water, detergents, solvents, or harsh chemicals and by friction, while allergic contact dermatitis is due to skin contact with substances that most people do not react to — most commonly nickel, perfume, rubber, hair dye, or preservatives. The acute forms are pruritic with erythema, edema, and micro- or macrovesiculation in the areas of skin contact by the initiating factor. The chronic forms are pruritic with milder erythema, scaling, lichenification, and possibly fissuring, particularly on the hands.
Seborrheic Dermatitis
Seborrheic dermatitis is a dermatitis that occurs in the vicinity of sebaceous glands and is caused by sebum overproduction. The condition tends to produce a scaly, flaky skin presentation.
Stasis Dermatitis
Stasis dermatitis is an inflammation on the lower legs caused by buildup of blood and fluid, and it is more likely to occur in people with varicose veins.
Dermatitis Herpetiformis
Dermatitis herpetiformis is one of the less common forms. It is characterized by intensely itchy, chronic papulovesicular eruptions, usually distributed symmetrically on extensor surfaces such as the back of neck, scalp, elbows, knees, back, hairline, groin, or face.
Acute vs. Chronic Presentation
Acute eczema demonstrates various rashes: erythema, papules, vesicles, pustules, crusts, erosion, clinical scaling, and histopathological spongiosis. Chronic eczema, by contrast, reveals lichenification and histopathological acanthosis.
Body Systems Involved
The Skin Barrier
Although the various types of dermatitis are characterized by different etiological factors, a key issue in all clinical presentations is dysfunction of the epidermal barrier. An altered skin barrier is the initial step that starts the so-called "vicious circle" of atopic dermatitis, characterized by dryness, tendency to itching and scratching, risk of superinfections, inflammation, pain, and sleep disturbances.
The outermost layer of the epidermis, the stratum corneum, consists of tightly packed corneocytes embedded in a lipid matrix composed of ceramides, cholesterol, and free fatty acids — the so-called "brick-and-mortar" structure that is crucial for reducing transepidermal water loss (TEWL) to maintain skin hydration. Filaggrin is a key structural protein that aggregates keratin filaments and later breaks down into peptides, amino acids, and key natural moisturizing factor (NMF) components, including trans-urocanic acid and pyrrolidone carboxylic acid. NMFs help retain water in the stratum corneum, maintain an acidic pH, and support enzymatic activity in keratinocytes, enhancing skin softness and flexibility while preventing dry skin and itching.
The Immune System
Atopic dermatitis, the most common chronic inflammatory skin disease, is driven by both terminal keratinocyte differentiation defects and strong type 2 immune responses. It is characterized by dysregulated immune responses that consist of an increased systemic Th2 response and a combination of Th2 and Th1 responses in the skin lesions.
Contact dermatitis is an inflammatory condition of the skin either of irritant exposure without specific adaptive immunologic pathogenesis or of allergic sensitization with specific adaptive immunologic pathogenesis. Both involve innate and acquired immune system responses including arachidonic acid and cytokine components that initiate and propagate the disease through cell-to-cell messaging by eicosanoid and/or cytokine moieties produced by epidermal cells, macrophages, dendritic cells, neutrophils, eosinophils, and various T and B lymphocytes.
It has long been believed that irritant contact dermatitis is caused by a stimulus while allergic contact dermatitis is a delayed-type hypersensitivity reaction involving T cells and antigen-presenting dendritic cells. Recent studies have demonstrated that the innate immune system plays an important role in contact dermatitis. The reduction in antimicrobial peptides, diminished recruitment of innate immune cells (PMNs, pDC, and NK cells) to the skin, epithelial barrier disruption, and TLR2 defects are some of the explanations for AD patients' susceptibility to pathogens such as Staphylococcus aureus, herpes simplex virus, and vaccinia virus.
The Gut–Skin Axis and the Microbiome
The intestinal microbiota plays a significant role in health and disease. It is sometimes referred to as the "forgotten organ." The microbiota is involved in various metabolic functions such as fermentation and absorption of undigested carbohydrates. More importantly, the microbiota interacts with the immune system, providing signals that promote the maturation of specific immune cells and the development of immune function.
Atopic dermatitis is associated with disturbance in the gut microbiota, though the dietary factors behind this dysbiosis are still being investigated. In human research, microbial diversity has been found to decline markedly in AD patients, with reductions in Firmicutes and Bacteroidota, but enrichment in Actinobacteriota and Bifidobacterium. Together, these findings suggest a novel diet–microbiota–immune axis in the pathogenesis of AD.
Research has shown that Staphylococcus aureus was present only on AD skin, while Staphylococcus hominis, Cutibacterium acnes, and Malassezia globosa were significantly more abundant on healthy control skin.
Contributing and Associated Factors
Genetics
The causes of AD are complex and include genetic and environmental factors. Genetic linkage analysis has identified AD loci on chromosomes 1q21, 17q25, and 20p. Evidence has shown that loss and mutations in the gene encoding filaggrin are closely related to AD onset and development. Atopic dermatitis is a genetically determined disease that is part of the broader disease complex of atopy that includes asthma, hay fever, and atopic dermatitis.
Immune Dysregulation and the Atopic March
Not all children follow the full trajectory; only a subset transition from atopic dermatitis to allergic rhinitis, asthma, and food allergies. This reflects the importance of the genetic and environmental risk factors that drive the immune mechanism of type 2 (Th2) inflammation, and underscores the importance of controlling AD early in life to prevent further progression of the atopic march.
Environmental Triggers
Although genetics play an important role in the onset of AD, changes in environmental factors are significantly associated with the increase in prevalence in recent years. Individuals with AD are commonly stimulated by allergens including pollen, dust mite, and animal dander. Use of harsh alkaline detergents in skin care products may unfavorably alter the skin's pH, causing downstream changes in enzyme activity and triggering inflammation. Environmental pollutants can trigger responses from both the innate and adaptive immune pathways.
Microbial Factors
Provoking factors in the pathogenesis of AD include microbial factors, psychosomatic interactions, contact allergens and irritants, inhalant allergens, food, and climate.
The Western Diet and Dietary Patterns
In recent decades, there has been a global increase in the prevalence of Western-style diets in Europe. These diets include processed foods, "junk food," convenience products, sugary drinks, and animal products, which have reduced fiber, vitamin, and mineral content. These foods and their consumption have further spread from high-income to low-income countries, and with them, there has been a concomitant increase in associated diseases.
Dietary patterns in AD patients show lower consumption of refined grains and higher intake of vegetables and fruits, which strongly correlate with microbial shifts in the gut ecosystem.
Breastfeeding
A Global Burden of Disease analysis revealed that discontinuous breastfeeding was a highly significant risk factor for childhood AD (R² = 0.21, p<0.001). An analysis of NHANES data corroborated this, showing that children with AD had a significantly shorter median breastfeeding duration than healthy children (5.1 vs. 6.1 months, p = 0.03), and each additional month of breastfeeding was associated with a 3% reduction in the odds of having AD. However, the literature is not entirely uniform: many studies have been conducted to evaluate the relationship between breastfeeding and allergy, and the results are inconsistent — showing protection against allergy, no effects, and even increased risk for allergy in different cohorts.
Psychological Stress
Among the predisposing and provoking factors reviewed in the immunopathogenesis literature are genetics, disturbance of skin function, T cell dysfunction, biphasic cytokine expression, and psychosomatic interactions, illustrating that psychological stress is documented in peer-reviewed literature as a provoking factor in AD flares.
Nutrients, Herbs, and Natural Ingredients: Traditional Use and Scientific Evidence
Essential Fatty Acids
Omega-3 Fatty Acids (EPA and DHA)
Proposed mechanism: EPA-derived 12-hydroxyeicosapentaenoic acid (12-HEPE) has been shown to inhibit neutrophil infiltration by suppressing CXCL1 and CXCL2 expression in keratinocytes via the retinoid X receptor α pathway, reducing local inflammation. Alterations in the lipid mediator profile further enhance the resolution of inflammatory skin conditions by decreasing pro-inflammatory arachidonic acid-derived metabolites while increasing anti-inflammatory lipid mediators.
Scientific evidence: The use of omega-3 fatty acids in the treatment of atopic dermatitis is an area of ongoing research. Some studies suggest that dietary supplementation can help manage symptoms of AD by reducing lesion severity, skin inflammation, dryness, and itching, while others show no significant beneficial effect.
One study aimed to evaluate the effect of omega-3 FA from fish oil in combination with gamma-linolenic acid (GLA) from blackcurrant seed oil in children with AD, designed as a longitudinal, prospective, randomized, triple-blind, placebo-controlled parallel clinical trial. The study was conducted over a 2-year period across autumn, winter, and spring, avoiding summer when AD usually improves. Children were randomized to receive the active product containing a specific blend of omega-3 and omega-6 fatty acids or placebo. Results from this trial suggest that supplementation with omega-3 fatty acids improved itchiness, sleep quality, disease severity, and quality of life in children diagnosed with atopic dermatitis, and researchers observed a decrease in the use of topical corticosteroids among those in the intervention group.
While the use of gamma-linolenic acid, a long-chain fatty acid of the omega-6 family, has proven unsuccessful in the prevention or treatment of atopic dermatitis, supplementation of long-chain omega-3 fatty acids may represent a promising approach in the prevention of allergic disorders, especially atopic dermatitis.
Evidence strength: Additional research is needed to verify results and standardize an effective dose for symptom management in atopic dermatitis. Overall, the evidence is preliminary and mixed.
Gamma-Linolenic Acid (GLA): Evening Primrose Oil and Borage Oil
Traditional use: Evening primrose oil (Oenothera biennis) has been used in European and North American herbal traditions for inflammatory skin conditions since at least the early 20th century. Borage seed oil (Borago officinalis), used historically in European herbalism, became of medical interest for skin disorders in the latter 20th century.
Proposed mechanism: EFA deficiency replicates the symptoms of atopic dermatitis, and patients with atopic dermatitis have been reported to have imbalances in EFA levels. Although direct proof is lacking, it has been hypothesized that patients with atopic dermatitis have impaired activity of the delta-6-desaturase enzyme, affecting metabolism of linoleic acid to gamma-linolenic acid (GLA). As a consequence of impaired formation of GLA, endogenous production of prostaglandin E1 (PGE1) diminishes in atopic patients, leading to immune dysregulation and dominance of pro-inflammatory prostaglandins (PGE2 and PGF2), eventuating in dermatitis.
Evening primrose oil is a natural source of linoleic acid and GLA in relatively high concentration. Other rich natural sources of GLA are plant oils such as borage seed oil, black currant seed oil, hempseed oil, and spirulina.
Scientific evidence: A systematic review identified 12 clinical trials of oral or topical borage oil for the treatment of atopic dermatitis and one preventive trial. The results were highly variable, with the effect reported to be significant in five studies, insignificant in five studies, and mixed in two studies. Overall, the data suggest that nutritional supplementation with borage oil is unlikely to have a major clinical effect but may be useful in some individual patients with less severe atopic dermatitis who are seeking an alternative treatment.
For evening primrose oil specifically, a systematic review found that the largest and best-reported studies did not show convincing evidence of any benefit, and a subsequent double-blind RCT of high-dose GLA capsules in 151 people with atopic dermatitis found no statistically significant benefit for GLA supplementation when compared with placebo.
In contrast, a smaller open study found: EPO supplementation results in an increase in plasma GLA and its metabolite dihomo-gamma-linolenic acid (DGLA) correlating with clinical improvement of AD as assessed by the SCORAD index. The open study included 21 patients with AD; EPO (4–6 g) was administered daily for 12 weeks. A significant increase in plasma GLA and DGLA levels and a decrease in the objective SCORAD were observed 4 and 12 weeks after initiation of EPO treatment. The open (unblinded) design is a significant limitation of this finding.
Evidence strength: Conflicting. The overall body of controlled evidence does not support GLA-containing oils as reliably effective for AD, though individual response may vary. Evidence is weak to moderate for EPO; weak for borage oil.
Probiotics and Prebiotics
Scientific evidence: A meta-analysis of 20 RCTs assessing probiotics, alone or combined with prebiotics, revealed a significant reduction in SCORAD scores, suggesting a consistent trend in alleviating AD symptoms in children without food allergies.
The clinical effect of probiotics in the treatment of AD in children using dichotomous variables was not statistically significant, but a meta-analysis of continuous variables showed that probiotics were significantly effective in treating AD in children. Subgroup analyses were performed based on the number of strains, the age of children, and the duration of treatment due to high heterogeneity. A statistically significant improvement in SCORAD was found with single-strain probiotics.
The most evidence was found on the effectiveness of probiotics on the clinical course of AD. Lactiplantibacillus plantarum, Ligilactobacillus salivarius, and Lactobacillus acidophilus specifically showed evidence of efficacy and safety across multiple studies (6/18, 33%).
Nonetheless, evidence for other dietary interventions, including prebiotics, remains limited, underscoring the necessity for well-designed intervention studies targeting multiple factors to understand etiological interactions and propose reliable manipulation strategies.
Evidence strength: Moderate. Probiotics represent the most consistently supported nutritional intervention in the AD literature reviewed, though heterogeneity across trials (strains, doses, populations) limits firm conclusions.
Vitamin D
Scientific evidence: Current research suggests a correlation between serum vitamin D level and AD severity, and that vitamin D supplementation could have a potential therapeutic effect on AD. Multiple systematic reviews and meta-analyses have examined this relationship. Reviewed RCTs have examined vitamin D among other interventions including prebiotics, evening primrose oil, and substituting cow's milk formula with partially hydrolyzed whey milk formula.
The 2024 systematic review and meta-analysis by Nakhaei et al. (MDPI Nutrients) conducted searches across PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials for RCTs assessing vitamin D supplementation and AD severity. Main outcomes were determined by change in severity of AD measured by validated clinical tools including SCORAD, EASI, Physician Global Assessment, Body Surface Area, ADSI, POEM, DLQI, and Pruritus Numerical Rating Scale.
Evidence strength: Preliminary to moderate. Observational evidence consistently links lower vitamin D levels with greater AD severity, and some RCT data support supplementation; however, the evidence base is not yet sufficient to establish definitive dosing or confirm causality.
Zinc
Scientific evidence: Zinc is crucial for skin repair and regeneration, possessing anti-inflammatory and antioxidant properties that aid in reducing skin inflammation and promoting healing in AD. One open trial investigated dietary supplementation with polyunsaturated fatty acids of the omega-3 and omega-6 series together with vitamins and minerals, including zinc. Nineteen patients aged 17–43 years with moderate to severe atopic dermatitis participated. The mean SCORAD improved in 14 of 17 patients by more than 50% after 8 and 16 weeks of treatment (p<0.01 and p<0.001, respectively). However, the open nature of this trial and the small number of subjects are major limitations.
Evidence strength: Preliminary. While zinc's biological role in skin integrity and immunity is well established, isolated human clinical trial evidence specifically for dermatitis is limited.
Vitamin B12
Scientific evidence: Case report evidence has associated AD flares with hematic vitamin B12 deficiency. After oral supplementation, normal levels of vitamin B12 were recorded along with improved SCORAD index values. Although this study did not investigate the involvement of gut microbiota, it could represent a starting point for future research.
Evidence strength: Very preliminary (case report level only).
Nutritional Supplements — Overall Assessment
Overall, there is weak evidence to support any one nutritional supplement intervention for the alleviation of AD symptoms. This conclusion was drawn from a systematic review covering 18 studies involving 881 patients and evaluating vitamins, herbal compounds, single-ingredient nutritional supplements, and pre- and probiotics.
Herbal and Botanical Ingredients
Traditional Systems of Use
Herbal therapy for skin disorders has been used for thousands of years. Even our close biological relatives, the great apes, use herbal self-medication. Specific herbs and their uses developed regionally, based on locally available plants and through trade in ethnobotanical remedies. Systems of herbal use developed in Europe, the Middle East, Africa, India, China, Japan, Australia, and the Americas. Two well-known systems still in use are the Ayurvedic herbs of India and herb combinations developed as part of traditional Chinese medicine (TCM) in China.
Herbs have been utilized for ages in traditional medical systems such as Ayurveda, Traditional Chinese Medicine (TCM), and Western herbalism to soothe and treat skin disorders like eczema.
Traditional Chinese Medicine (TCM) Herbal Formulas
Traditional use: East Asian traditional medicines such as traditional Chinese medicine, traditional Korean medicine, and Kampo medicine have been used for health care in Asia for thousands of years. In recent years, traditional Chinese medicine (TCM) has been increasingly used in the treatment of AD. Many studies have shown that TCM mainly regulates inflammatory cytokines, gut microbiota, and the immune system, playing a crucial role in the treatment of AD. The treatment of AD using TCM is characterized by targeting multiple pathways and multiple targets, and it demonstrates significant therapeutic effects.
Scientific evidence: Chinese herbal medicine (CHM) has considerable benefits and low toxicity for the treatment of skin diseases and has a complete theoretical basis. Currently, there is growing interest in CHM as a potential complementary and alternative therapy. The treatment of atopic dermatitis with CHM is diverse and mainly divided into internal and external treatments, all of which are reported to have good efficacy.
Herbal medicine approaches are now popular not only in Asian countries but also in Western countries. Although solid evidence is still needed, some herbal medicines of both topical and oral administration have been shown to be effective in skin diseases including AD.
Evidence strength: Preliminary to moderate. Evidence is largely derived from studies conducted in Asia, with heterogeneity in formulations and populations. High-quality, replicated RCTs in diverse populations are still needed.
Colloidal Oatmeal (Avena sativa)
Traditional use: Oat-based preparations have been used in European bathing traditions for centuries to soothe inflamed and irritated skin.
Scientific evidence and regulatory status: Colloidal oatmeal compounds became commercially available for the treatment of inflammatory skin conditions in 1945. In 2003, the FDA approved colloidal oatmeal as a "skin protectant," meaning the agency considers it effective for alleviating dryness, itching, and discomfort caused by certain skin conditions, including AD.
Oats (Avena sativa) contain a wide array of phytochemicals including carbohydrates, proteins, lipids, flavonoids, avenanthramides, tocols, alkaloids, saponins, and sterols. The antioxidant and anti-inflammatory effect of colloidal oatmeal is due in particular to the presence of avenanthramides and vitamin E. Oats also contain hydrophilic carbohydrates that enhance moisture uptake and retention, as well as unsaturated triglycerides, flavonoids, tocols, alkaloids, and sterols that further exert barrier repair and anti-inflammatory effects. Oats contain vitamin E and ferulic acid that have antioxidant and anti-inflammatory properties.
Oat-based emollients have been linked to fewer flares and reduced use of topical corticosteroids in children with moderate AD. While colloidal oatmeal is generally safe and well-tolerated, healthcare providers should be aware of the potential for rare sensitization or allergic reactions, particularly in patients with AD or a compromised skin barrier.
Evidence strength: Moderate to strong for topical use. The FDA approval as an OTC skin protectant is notable regulatory recognition. Clinical studies support short-term symptom relief and skin barrier support.
Chamomile (Matricaria chamomilla)
Traditional use: Chamomile, or Matricaria flower, is one of the most commonly used medicinal plants, known for its anti-inflammatory properties. It has long been used in traditional Chinese medicine to treat eczema and other skin conditions.
Scientific evidence: Topical chamomile may help reduce irritation and discomfort from eczema. However, robust RCT data in humans specifically for dermatitis are limited, and most evidence is from in vitro or small observational studies.
Evidence strength: Weak (predominantly traditional use and in vitro data).
Turmeric / Curcumin (Curcuma longa)
Traditional use: Turmeric, known for its skin-benefiting properties in Ayurvedic medicine, contains curcumin, a potent antioxidant and anti-inflammatory compound.
Scientific evidence: Curcumin, the main ingredient in turmeric, has strong antioxidant and anti-inflammatory properties. However, clinical trial data specifically in dermatitis remain limited. Most evidence derives from in vitro and animal studies, with a small number of human trials in inflammatory conditions more broadly.
Evidence strength: Preliminary. Mechanistic plausibility is established; dedicated high-quality clinical trials for dermatitis are lacking.
Neem (Azadirachta indica)
Traditional use: Neem has been documented in Ayurvedic medicine for millennia and is described in Sanskrit texts as a remedy for skin disorders. Neem, with its antimicrobial elements, serves as an effective herbal remedy when applied topically in Ayurvedic practice for eczema conditions.
Scientific evidence: Evidence for neem in dermatitis in human clinical trials is limited. Most available data derive from in vitro antimicrobial and anti-inflammatory studies. No high-quality RCTs in dermatitis populations have been identified in the peer-reviewed literature at the time of writing.
Evidence strength: Preliminary (principally traditional use and in vitro data).
Licorice Root (Glycyrrhiza glabra)
Traditional use: Licorice root has been used in both TCM and European herbal traditions for centuries as an anti-inflammatory agent for skin conditions.
Scientific evidence: Licorice root extract shows anti-inflammatory activity in laboratory studies and limited clinical work suggesting reduced redness when formulated for skin. Human RCT evidence is scarce.
Evidence strength: Weak to preliminary (in vitro data and very limited clinical evidence).
Dietary and Lifestyle Factors
Mediterranean and Plant-Rich Dietary Patterns
Dietary patterns in AD patients show lower consumption of refined grains and higher intake of vegetables and fruits, which strongly correlate with microbial shifts. Functional predictions reveal reduced carbohydrate, amino acid, and energy metabolism pathways in gut microbiota. Together, these findings suggest a novel diet–microbiota–immune axis in the pathogenesis of AD.
Western Diet as a Risk-Associated Pattern
In recent decades, there has been a global increase in the prevalence of Western-style diets. These diets include processed foods, "junk food," convenience products, sugary drinks, and animal products with reduced fiber, vitamin, and mineral content. Multiple studies have associated Western dietary patterns with increased atopic disease prevalence. Allergic diseases represent an increasing problem in public health in most modern societies as their prevalence has risen markedly during recent decades, though the causes of this increase are not yet fully explained.
Food Allergy and Sensitization
Food allergy is documented among the key pathophysiological keywords in atopic dermatitis research. Food is cited as a provoking factor in the pathogenesis of AD in the immunopathogenesis literature. However, the relationship between food allergy and AD is complex: food sensitization may be a consequence as well as a trigger of skin barrier dysfunction, and elimination diets should be pursued based on documented allergy rather than assumption.
Skin Hygiene, pH, and Product Use
Use of harsh alkaline detergents in skin care products may unfavorably alter the skin's pH, causing downstream changes in enzyme activity and triggering inflammation. Maintaining an appropriately acidic skin pH is therefore an important lifestyle and product-selection consideration for individuals with AD and contact dermatitis.
Breastfeeding in Early Life
Breastfeeding during the first four months of life has been shown to modestly reduce the incidence of AD in infants at high risk, while exclusive breastfeeding for four to six months with weaning initiated at exactly 4 to 5 months may provide the lowest risk for developing AD in all children. Concurrent studies have found that breastfeeding during the first four months of life may result in a 33% reduction in the incidence and severity of AD in high-risk patients — those with a first-degree relative with atopy. Multiple confounding factors — including maternal immunity, maternal diet during pregnancy and lactation, breast milk composition, environment, and other lifestyles — make this relationship difficult to isolate definitively.
Psychological Stress and Psychosomatic Interactions
Psychosomatic interactions are recognized in the peer-reviewed literature as a provoking factor in AD flares. The contribution of predisposing, immunopathogenic, and provoking factors in the pathogenesis of AD includes psychosomatic interactions alongside genetics, T cell dysfunction, and cytokine expression changes. Stress-associated immune modulation is a plausible biological pathway, though intervention studies directly testing stress-reduction on dermatitis outcomes are limited.
Skin Microbiome and Topical Emollients
A healthy skin barrier protects the body from environmental insults and regulates moisture levels through a coordinated network of cellular and molecular components. The outermost layer of the epidermis, the stratum corneum, consists of tightly packed corneocytes embedded in a lipid matrix composed of ceramides, cholesterol, and free fatty acids. This "brick-and-mortar" structure is crucial for reducing transepidermal water loss to maintain skin hydration. Supporting the skin barrier through the use of appropriate emollients — including oat-based preparations — is a lifestyle and skincare strategy with documented clinical support.
Summary of Evidence Strength by Intervention
- Probiotics — Moderate. Best-supported nutritional intervention for AD; consistent reduction in SCORAD in meta-analyses of pediatric RCTs, though heterogeneity across strains and populations limits firm recommendations.
- Colloidal Oatmeal (topical) — Moderate to strong. FDA-recognized OTC skin protectant; multiple clinical studies support barrier repair and symptom relief.
- Vitamin D — Preliminary to moderate. Observational correlation between deficiency and AD severity is consistent; RCT evidence is supportive but not definitive.
- Omega-3 Fatty Acids — Preliminary, mixed. Some RCTs show benefit for itch and severity; others show no effect. Larger standardized trials are needed.
- Evening Primrose Oil / Borage Oil (GLA) — Weak to conflicting. Largest controlled trials show no significant benefit; smaller open studies report improvement. Overall evidence does not strongly support use.
- Zinc — Preliminary. Biological plausibility is strong; isolated RCT evidence for dermatitis is limited.
- Chinese Herbal Medicine — Preliminary to moderate. Growing body of RCT evidence from Asian populations; formulation heterogeneity and limited replication in Western populations restrict generalizability.
- Chamomile, Turmeric, Neem, Licorice — Weak to preliminary. Predominantly traditional use, in vitro, or animal data. Human clinical trial evidence for dermatitis is sparse.
- Vitamin B12 — Very preliminary (case report level).
References
- Nakada T. "Special Issue: Molecular Studies of Dermatitis: From Mechanism to Therapy." Int J Mol Sci. 2024;25(5):2696. PMC10931647.
- Ong PY, Leung DYM. "Immune dysregulation in atopic dermatitis." Curr Allergy Asthma Rep. 2006;6(5):384–389. PMID 16899200.
- Leung DYM. "Atopic dermatitis: a disease caused by innate immune defects?" J Invest Dermatol. 2009;129(1):14–19. PMID 19078985.
- Brunner PM, Guttman-Yassky E, Leung DYM. "The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies." J Allergy Clin Immunol. 2017;139(4S):S65–S76. PMID 28390479.
- Hansen-Sackey T et al. "Atopic Dermatitis: Pathophysiology and Emerging Treatments." Allergies. 2025;5(4):40.
- Leung DYM, Boguniewicz M, et al. "Atopic dermatitis: review of immunopathogenesis and advances in immunosuppressive therapy." Acta Derm Venereol. 2003;83(1):1–7. PMID 12423430.
- Niseteo T, Hojsak I, Ožanić Bulić S, Pustišek N. "Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children." Nutrients. 2024;16(17):2829. PMC11397185.
- Balic A et al. "Do long-chain omega-3 fatty acids protect from atopic dermatitis?" J Dtsch Dermatol Ges. 2016;14(5):491–498. PMID 26882378.
- Eriksen BB, Kare LD. "Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis." J Dermatolog Treat. 2006;17(2):82–85. PMID 16766331.
- Review of Omega-3 Fatty Acid Dietary Supplementation in Cutaneous Inflammatory Disorders. Journal of Integrative Dermatology.
- Foster RH, Hardy G, Alany RG. "Borage oil in the treatment of atopic dermatitis." Nutrition. 2010;26(7–8):708–718. PMID 20579590.
- Seher Eken et al. "Gamma-Linolenic Acid Levels Correlate with Clinical Efficacy of Evening Primrose Oil in Patients with Atopic Dermatitis." Dermatology Research and Practice. 2014. PMC3930832.
- Williams HC. "Evening primrose oil for atopic dermatitis: Time to say goodnight." BMJ. 2003;327(7428):1358–1359. PMC292973.
- Zhu Y et al. "Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta-analysis." Pediatric Allergy and Immunology. 2023. PMC10349543.
- Vassilopoulou E et al. "A systematic review and meta-analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: An EAACI task force report." Allergy. 2024.
- Lam M et al. "Clinical Efficacy of Nutritional Supplements in Atopic Dermatitis: Systematic Review." JMIR Dermatology. 2023. PMC10719823.
- Nakhaei AE et al. "Vitamin D Supplementation for Treating Atopic Dermatitis in Children and Adults: A Systematic Review and Meta-Analysis." Nutrients. 2024;16(23):4128.
- Colucci R et al. "The Western Diet and Atopic Dermatitis: The Potential Role of Nutrients, Contaminants, and Additives in Dysbiosis and Epithelial Barrier Dysfunction." PMC12024387.
- Dietary modulation of gut microbiota and its role in atopic dermatitis: integrative evidence from animal and human studies. PMC12545045.
- Fang Z et al. "Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review." Front Immunol. 2021;12:720393.
- Nath S et al. "Dysbiotic Lesional Microbiome With Filaggrin Missense Variants Associate With Atopic Dermatitis in India." Front Cell Infect Microbiol. 2020;10:570423. PMC7705349.
- The Association Between Breastfeeding and Atopic Dermatitis: An Epidemiological Analysis of Global and National Datasets. PMC12809613.
- Lien TY, Goldman RD. "Update: Can breastfeeding and maternal diet prevent atopic dermatitis?" Can Fam Physician. 2017. PMC5630244.
- Ehrlich SD. "Herbal Treatment for Dermatologic Disorders." In: Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. NCBI Bookshelf NBK92761.
- Wang H et al. "Efficacy and safety of Chinese herbal medicine for atopic dermatitis: Evidence from eight high-quality randomized placebo-controlled trials." Front Pharmacol. 2022. PMC9551201.
- Yang G et al. "Effectiveness and Safety of Herbal Medicine for Atopic Dermatitis: An Overview of Systematic Reviews." J Clin Med. 2020. PMC7382724.
- Zhang L et al. "Selected traditional Chinese herbal medicines for the treatment of atopic dermatitis - research progress on the effect and mechanism of actions." Front Pharmacol. 2025. PMC11978831.
- Fowler JF Jr. "Colloidal Oatmeal Formulations and the Treatment of Atopic Dermatitis." J Drugs Dermatol. 2014;13(10):1180–1185.
- Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants? Journal of Dermatological Treatment. 2025.
- The Role of the Western Diet on Atopic Dermatitis: Our Experience and Review of the Current Literature. PMC10534346.
- Herbert OCH et al. "Western Lifestyle and Increased Prevalence of Atopic Diseases: An Example from a Small Papua New Guinean Island." World Allergy Organ J. 2009. PMC3650959.
- Modulation of allergic contact dermatitis via gut microbiota modified by diet, vitamins, probiotics, prebiotics, and antibiotics. Pharmacological Reports. 2023.
Go back